{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T21:09:43Z","timestamp":1789852183279,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2003,12,18]],"date-time":"2003-12-18T00:00:00Z","timestamp":1071705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,12,18]],"date-time":"2003-12-18T00:00:00Z","timestamp":1071705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2004,3,1]]},"DOI":"10.1038\/sj.leu.2403245","type":"journal-article","created":{"date-parts":[[2004,1,8]],"date-time":"2004-01-08T10:29:04Z","timestamp":1073557744000},"page":"607-615","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["N-(4-hydroxyphenyl)retinamide induces growth arrest and apoptosis in HTLV-I-transformed cells"],"prefix":"10.1038","volume":"18","author":[{"given":"N","family":"Darwiche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Hatoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Dbaibo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Kadara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Abou-Lteif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Bazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Hermine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H de","family":"Th\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Bazarbachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,12,18]]},"reference":[{"key":"BF2403245_CR1","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1096\/fasebj.5.14.1661245","volume":"14","author":"LM De Luca","year":"1991","unstructured":"De Luca LM . Retinoids and their receptors in differentiation, embryogenesis, and neoplasia. FASEB J 1991; 14: 2924\u20132933.","journal-title":"FASEB J"},{"key":"BF2403245_CR2","doi-asserted-by":"publisher","first-page":"479S","DOI":"10.1093\/jn\/130.2.479S","volume":"130","author":"SM Lippman","year":"2000","unstructured":"Lippman SM, Lotan R . Advances in the development of retinoids as chemopreventive agents. Symposium: diet, natural products and cancer prevention. J Nutr 2000; 130: 479S\u2013482S.","journal-title":"J Nutr"},{"key":"BF2403245_CR3","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/sj.leu.2402414","volume":"16","author":"JA Fontana","year":"2002","unstructured":"Fontana JA, Rishi AK . Classical and novel retinoids: their targets in cancer therapy. Leukemia 2002; 16: 463\u2013472.","journal-title":"Leukemia"},{"key":"BF2403245_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1056\/NEJM199307153290307","volume":"329","author":"R Warrell","year":"1993","unstructured":"Warrell R, de Th\u00e9 H, Wang Z, Degos L . Acute promyelocytic leukemia. N Engl J Med 1993; 329: 177\u2013189.","journal-title":"N Engl J Med"},{"key":"BF2403245_CR5","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.1182\/blood.V98.9.2862","volume":"98","author":"B Cassinat","year":"2001","unstructured":"Cassinat B, Chevret S, Zassadowski F, Balitrand N, Guillemot I, Menot ML et al. In vitro all-trans retinoic acid sensitivity of acute promyelocytic leukemia blasts: a novel indicator of poor patient outcome. Blood 2001; 98: 2862\u20132864.","journal-title":"Blood"},{"key":"BF2403245_CR6","doi-asserted-by":"crossref","unstructured":"Dawson MI, Zhang X, Hobbs PD, Jong L In: Livrea MA (ed). Vitamin A and Retinoids: an Update of Biological Aspects and Clinical Applications: Synthetic Retinoids and Their Usefulness in Biology and Medicine##Basel: Birkhauser, Verlag, 2000, pp. 161\u2013196.","DOI":"10.1007\/978-3-0348-8454-9_14"},{"key":"BF2403245_CR7","first-page":"6036","volume":"53","author":"D Delia","year":"1993","unstructured":"Delia D, Aiellom A, Lombardim L, Giuseppem P, Pelicci G, Grignani G et al. N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid. Cancer Res 1993; 53: 6036\u20136041.","journal-title":"Cancer Res"},{"key":"BF2403245_CR8","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1023\/A:1011342220621","volume":"6","author":"JM Wu","year":"2001","unstructured":"Wu JM, DiPietrantonio AM, Hsieh TC . Mechanism of fenretinide (HPR)-induced cell death. Apoptosis 2001; 6: 377\u2013388.","journal-title":"Apoptosis"},{"key":"BF2403245_CR9","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1200\/JCO.1993.11.10.2036","volume":"11","author":"F Formelli","year":"1993","unstructured":"Formelli F, Clerici M, Campa T, Di Mauro MG, Magni A, Moglia D et al. Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations. J Clin Oncol 1993; 11: 2036\u20132042.","journal-title":"J Clin Oncol"},{"key":"BF2403245_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1006\/gyno.2002.6663","volume":"86","author":"G De Palo","year":"2002","unstructured":"De Palo G, Mariani L, Camerini T, Marubini E, Formelli F, Pasini B et al. Effect of fenretinide on ovarian carcinoma occurrence. Gynecol Oncol 2002; 86: 24\u201327.","journal-title":"Gynecol Oncol"},{"key":"BF2403245_CR11","first-page":"2835","volume":"8","author":"SE Singletary","year":"2002","unstructured":"Singletary SE, Atkinson EN, Hoque A, Sneige N, Sahin AA, Fritsche HA et al. Phase II clinical trial of N-(4-hydroxyphenyl)retinamide and tamoxifen administration before definitive surgery for breast neoplasia. Clin Cancer Res 2002; 8: 2835\u20132842.","journal-title":"Clin Cancer Res"},{"key":"BF2403245_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0168-1702(01)00286-6","volume":"78","author":"A Bazarbachi","year":"2001","unstructured":"Bazarbachi A, Hermine O . Treatment of adult T-cell leukaemia\/lymphoma: current strategy and future perspectives. Virus Res 2001; 78: 79\u201392.","journal-title":"Virus Res"},{"key":"BF2403245_CR13","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1056\/NEJM199506293322604","volume":"332","author":"OD Hermine","year":"1995","unstructured":"Hermine OD, Bouscary A, Gessain A, Turlure P, Leblond V, Franck N et al. Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa. N Engl J Med 1995; 332: 1749\u20131751.","journal-title":"N Engl J Med"},{"key":"BF2403245_CR14","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/00042560-199600001-00028","volume":"1","author":"A Bazarbachi","year":"1996","unstructured":"Bazarbachi A, Hermine O . Treatment with a combination of zidovudine and alpha-interferon in naive and pretreated adult T-cell leukemia\/lymphoma patients. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 1: 186\u2013190.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"BF2403245_CR15","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/sj.thj.6200195","volume":"3","author":"O Hermine","year":"2002","unstructured":"Hermine O, Allard I, L\u00e9vy V, Arnulf B, Gessain A, Bazarbachi A . A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia\/lymphoma. Hematol J 2002; 3: 276\u2013282.","journal-title":"Hematol J"},{"key":"BF2403245_CR16","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1182\/blood.V93.1.278","volume":"93","author":"A Bazarbachi","year":"1999","unstructured":"Bazarbachi A, El-Sabban ME, Nasr R, Hermine O, de The H . Arsenic trioxide and interferon-alpha synergize to induce cell cycle arrest and apoptosis in human T-cell lymphotropic virus type I-transformed cells. Blood 1999; 93: 278\u2013283.","journal-title":"Blood"},{"key":"BF2403245_CR17","first-page":"2849","volume":"96","author":"ME El-Sabban","year":"2000","unstructured":"El-Sabban ME, Nasr R, Dbaibo G, Hermine O, Abboushi N, Quignon F et al. Arsenic-interferon-alpha-triggered apoptosis in HTLV-I transformed cells is associated with tax down-regulation and reversal of NF-kappa B activation. Blood 2000; 96: 2849\u20132855.","journal-title":"Blood"},{"key":"BF2403245_CR18","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.1182\/blood-2002-09-2986","volume":"101","author":"R Nasr","year":"2003","unstructured":"Nasr R, Rosenwald A, El-Sabban ME, Arnulf B, Zalloua P, Lepelletier Y, Bex F et al. Arsenic\/interferon specifically reverses two distinct gene networks critical for the survival of HTLV-I infected leukemic cells. Blood 2003; 101: 4576\u20134582.","journal-title":"Blood"},{"key":"BF2403245_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/sj.thj.6200098","volume":"2","author":"N Darwiche","year":"2001","unstructured":"Darwiche N, El-Sabban M, Bazzi R, Nasr R, Al-Hashimi S, Hermine O et al. Retinoic acid dramatically enhances the arsenic trioxide induced cell cycle arrest and apoptosis in retinoic acid receptor \u03b1-positive Human T cell leukemiavirus type-I transformed cells. Hematol J 2001; 2: 127\u2013135.","journal-title":"Hematol J"},{"key":"BF2403245_CR20","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/sj.leu.2400593","volume":"11","author":"JI Miyatake","year":"1997","unstructured":"Miyatake JI, Maeda Y . Inhibition of proliferation and CD25 down-regulation by retinoic acid in human adult T cell leukemia. Leukemia 1997; 11: 401\u2013407.","journal-title":"Leukemia"},{"key":"BF2403245_CR21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3109\/10428199709114166","volume":"25","author":"LN Chan","year":"1997","unstructured":"Chan LN, Zhang S, Shao J, Waikel R, Thompson EA, Chan TS . N-(4-hydroxyphenyl)retinamide induces apoptosis in T lymphoma and T lymphoblastoid leukemia cells. Leuk Lymphoma 1997; 25: 271\u2013280.","journal-title":"Leuk Lymphoma"},{"key":"BF2403245_CR22","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/sj.leu.2402485","volume":"5","author":"PH O'Donnell","year":"2002","unstructured":"O'Donnell PH, Guo WX, Reynolds CP, Maurer BJ . N-(4-hydroxyphenyl)retinamide increases ceramide and is cytotoxic to acute lymphoblastic leukemia cell lines, but not to non-malignant lymphocytes. Leukemia 2002; 5: 902\u2013910.","journal-title":"Leukemia"},{"key":"BF2403245_CR23","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1093\/carcin\/22.12.1955","volume":"22","author":"A Hatoum","year":"2001","unstructured":"Hatoum A, El-Sabban ME, Khoury J, Yuspa SH, Darwiche N . Overexpression of retinoic acid receptors alpha and gamma into neoplastic epidermal cells causes retinoic acid-induced growth arrest and apoptosis. Carcinogenesis 2001; 22: 1955\u20131963.","journal-title":"Carcinogenesis"},{"key":"BF2403245_CR24","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1139\/y59-099","volume":"37","author":"EG Bligh","year":"1959","unstructured":"Bligh EG, Dyer WJ . A rapid method of total lipid extraction and purification. Can J Biochem Phys 1959; 37: 911\u2013917.","journal-title":"Can J Biochem Phys"},{"key":"BF2403245_CR25","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1006\/abio.2001.5342","volume":"298","author":"A Bielawska","year":"2001","unstructured":"Bielawska A, Perry DK, Hannun YA . Determination of ceramides and diglycerides by the diglyceride kinase assay. Anal Biochem 2001; 298: 141\u2013150.","journal-title":"Anal Biochem"},{"key":"BF2403245_CR26","unstructured":"Zar JH . Biostatistical Analysis. 4th edn New Jersey: Prentice Hall, 1999."},{"key":"BF2403245_CR27","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1093\/carcin\/23.3.447","volume":"3","author":"S Bruno","year":"2002","unstructured":"Bruno S, Tenca C, Saverino D, Ciccone E, Grossi CE . Apoptosis of squamous cells at different stages of carcinogenesis following 4-HPR treatment. Carcinogenesis 2002; 3: 447\u2013456.","journal-title":"Carcinogenesis"},{"key":"BF2403245_CR28","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1182\/blood.V85.2.359.359","volume":"15","author":"D Delia","year":"1995","unstructured":"Delia D, Aiello A, Formelli F, Fontanella E, Costa A, Miyashita T et al. Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl)retinamide and effect of deregulated bcl-2. Blood 1995; 15: 359\u2013367.","journal-title":"Blood"},{"key":"BF2403245_CR29","first-page":"403","volume":"5","author":"SY Sun","year":"1999","unstructured":"Sun SY, Yue P, Lotan R . Induction of apoptosis by N-(4-hydroxyphenyl)retinamide and its association with reactive oxygen species, nuclear retinoic acid receptors, and apoptosis related genes in human prostate carcinoma cells. Mol Pharmacol 1999; 5: 403\u2013410.","journal-title":"Mol Pharmacol"},{"key":"BF2403245_CR30","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1038\/sj.bjc.6600356","volume":"12","author":"A Asumendi","year":"2002","unstructured":"Asumendi A, Morales MC, Alvarez A, Arechaga J, Perez-Yarza G . Implication of mitochondria-derived ROS and cardiolipin peroxidation in N-(4-hydroxyphenyl) retinamide-induced apoptosis. Br J Cancer 2002; 12: 1951\u20131956.","journal-title":"Br J Cancer"},{"key":"BF2403245_CR31","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1177\/154411130201300603","volume":"13","author":"WC Weinberg","year":"2002","unstructured":"Weinberg WC, Denning MF . P21Waf1 control of epithelial cell cycle and cell fate. Crit Rev Oral Biol Med 2002; 13: 453\u2013464.","journal-title":"Crit Rev Oral Biol Med"},{"key":"BF2403245_CR32","first-page":"639","volume":"1","author":"AL Gartel","year":"2002","unstructured":"Gartel AL, Tyner AL . The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 2002; 1: 639\u2013649.","journal-title":"Mol Cancer Ther"},{"key":"BF2403245_CR33","first-page":"4331","volume":"15","author":"AM DiPietrantonio","year":"2000","unstructured":"DiPietrantonio AM, Hsieh TC, Juan G, Traganos F, Darzynkiewicz Z, Wu JM . Fenretinide-induced caspase 3 activity involves increased protein stability in a mechanism distinct from reactive oxygen species elevation. Cancer Res 2000; 15: 4331\u20134335.","journal-title":"Cancer Res"},{"key":"BF2403245_CR34","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0145-2126(02)00162-5","volume":"3","author":"S Faderl","year":"2003","unstructured":"Faderl S, Lotan R, Kantarjian HM, Harris D, Van Q, Estrov Z . N-(4-hydroxylphenyl)retinamide (fenretinide, 4-HPR), a retinoid compound with antileukemic and proapoptotic activity in acute lymphoblastic leukemia (ALL). Leuk Res 2003; 3: 259\u2013266.","journal-title":"Leuk Res"},{"key":"BF2403245_CR35","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/(SICI)1097-0215(19980925)78:1<53::AID-IJC10>3.0.CO;2-6","volume":"78","author":"AM DiPietrantonio","year":"1998","unstructured":"DiPietrantonio AM, Hsieh TC, Olson SC, Wu J M . Altered expression of the G1\/S checkpoint regulators (cyclin D1, cdk4, pRB) and transient modulation of poly(ADP-ribose) polymerase and ceramide level changes by fenretinide N-(4-hydroxyphenyl) retinamide, 4-HPR) in human promyelocytic HL-60 leukemic cells. Int J Cancer 1998; 78: 53\u201361.","journal-title":"Int J Cancer"},{"key":"BF2403245_CR36","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/jnci\/91.13.1138","volume":"9","author":"BJ Maurer","year":"1999","unstructured":"Maurer BJ, Metelitsa LS, Seeger RC, Cabot MC, Reynolds CP . Increase in ceramide and induction of mixed apoptosis\/necrosis by N-(4-hydroxyphenyl)retinamide in neuroblastoma cell lines. J Natl Cancer Inst 1999; 9: 1138\u20131146.","journal-title":"J Natl Cancer Inst"},{"key":"BF2403245_CR37","first-page":"403","volume":"55","author":"SY Sun","year":"1999","unstructured":"Sun SY, Yue P, Lotan R . Induction of apoptosis by N-(4-hydroxyphenyl)retinamide and its association with reactive oxygen species, nuclear retinoic acid receptors, and apoptosis related genes in human prostate carcinoma cells. Mol Pharmacol 1999; 55: 403\u2013410.","journal-title":"Mol Pharmacol"},{"key":"BF2403245_CR38","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1359-6101(00)00028-9","volume":"12","author":"KT Jeang","year":"2001","unstructured":"Jeang KT . Functional activities of the human T-cell leukemia virus type I Tax oncoprotein: cellular signaling through NF-kappa B. Cytokine Growth Factor Rev 2001; 12: 207\u2013217.","journal-title":"Cytokine Growth Factor Rev"},{"key":"BF2403245_CR39","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1182\/blood.V88.5.1551.1551","volume":"88","author":"A Cereseto","year":"1996","unstructured":"Cereseto A, Diella F, Mulloy JC, Cara A, Michieli P, Grassmann R et al. p53 functional impairment and high p21waf1\/cip1 expression in human T-cell lymphotropic\/leukemia virus type I-transformed T cells. Blood 1996; 88: 1551\u20131560.","journal-title":"Blood"},{"key":"BF2403245_CR40","doi-asserted-by":"publisher","first-page":"7270","DOI":"10.1128\/JVI.74.16.7270-7283.2000","volume":"74","author":"C de La Fuente","year":"2000","unstructured":"de La Fuente C, Santiago F, Chong SY, Deng L, Mayhood T, Fu P et al. Overexpression of p21(waf1) in human T-cell lymphotropic virus type 1-infected cells and its association with cyclin A\/cdk2. J Virol 2000; 74: 7270\u20137283.","journal-title":"J Virol"},{"key":"BF2403245_CR41","doi-asserted-by":"publisher","first-page":"7291","DOI":"10.1128\/JVI.77.13.7291-7299.2003","volume":"77","author":"S Kawata","year":"2003","unstructured":"Kawata S, Ariumi Y, Shimotohno K . p21(Waf1\/Cip1\/Sdi1) prevents apoptosis as well as stimulates growth in cells transformed or immortalized by human T-cell leukemia virus type 1-encoded tax. J Virol 2003; 77: 7291\u20137299.","journal-title":"J Virol"},{"key":"BF2403245_CR42","first-page":"76","volume":"92","author":"C Gisselbrecht","year":"1998","unstructured":"Gisselbrecht C, Gaulard P, Lepage E, Coiffier B, Briere J, Haioun C et al. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d' Etudes des Lymphomes de l' Adulte. Blood 1998; 92: 76\u201382.","journal-title":"Blood"},{"key":"BF2403245_CR43","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1200\/JCO.1994.12.6.1185","volume":"12","author":"AL Cheng","year":"1994","unstructured":"Cheng AL, Su IJ, Chen CC, Tien HF . Use of retinoic acids in the treatment of peripheral T-cell lymphoma: a pilot study. J Clin Oncol 1994; 12: 1185\u20131192.","journal-title":"J Clin Oncol"},{"key":"BF2403245_CR44","first-page":"343","volume":"72","author":"M Toshima","year":"2000","unstructured":"Toshima M, Nagai T, Izumi T, Tarumoto T, Imagawa S, Komatsu N et al. All-trans-retinoic acid treatment for chemotherapy-resistant acute adult T-cell leukemia. Int J Hematol 2000; 72: 343\u2013345.","journal-title":"Int J Hematol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2403245.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403245","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403245.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T01:40:43Z","timestamp":1648777243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2403245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12,18]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3,1]]}},"alternative-id":["BF2403245"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2403245","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12,18]]},"assertion":[{"value":"29 July 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}